Addus HomeCare (NASDAQ:ADUS) EVP Sells $29,922.24 in Stock

Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) EVP Roberton James Stevenson sold 284 shares of the stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $29,922.24. Following the completion of the sale, the executive vice president owned 14,030 shares in the company, valued at $1,478,200.80. This trade represents a 1.98% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Roberton James Stevenson also recently made the following trade(s):

  • On Tuesday, February 24th, Roberton James Stevenson sold 567 shares of Addus HomeCare stock. The stock was sold at an average price of $107.35, for a total value of $60,867.45.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $103.53 on Friday. The stock’s 50-day simple moving average is $109.22 and its two-hundred day simple moving average is $112.95. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The firm has a market capitalization of $1.92 billion, a P/E ratio of 19.87, a P/E/G ratio of 1.44 and a beta of 0.91. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11.

Analyst Ratings Changes

Several brokerages have issued reports on ADUS. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday. BMO Capital Markets started coverage on shares of Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective on the stock. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday, February 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Finally, TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $134.33.

Get Our Latest Report on ADUS

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Royal Bank of Canada lifted its stake in shares of Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after acquiring an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Addus HomeCare by 6.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after purchasing an additional 2,952 shares during the period. Jane Street Group LLC increased its stake in Addus HomeCare by 387.6% in the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after purchasing an additional 8,780 shares during the period. Finally, Intech Investment Management LLC lifted its position in Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after purchasing an additional 4,439 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare News Summary

Here are the key news stories impacting Addus HomeCare this week:

  • Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
  • Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
  • Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
  • Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
  • Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
  • Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.